QUESTIONS & ANSWERS
Clear answers while ELX-13 takes shape.
Here is what is confirmed in the brief and what remains part of development.
What is ELX-13?
ELX-13 is a collection of premium Mediterranean botanical drinks in development. The planned range is Olive, Saffron and Mastic, each in a still 355 ml ready-to-drink format.
Can I buy ELX-13 now?
ELX-13 is not yet available to purchase. Join the Founding List for development updates and launch news. Joining does not reserve a product.
When will ELX-13 launch?
A launch date has not been confirmed. Timing depends on funding, development, testing and readiness for release.
Will ELX-13 be zero sugar and naturally sweetened?
Those are our development targets. The recipe, sweetener and measured nutritional values must be confirmed before they become final product claims.
Will ELX-13 contain vitamin B3?
Nicotinamide vitamin B3 is part of the development brief, alongside vitamin C and zinc. Final forms and amounts have not been confirmed.
Where will the botanicals come from?
Greek and Mediterranean ingredients inspire the range. The sourcing direction includes olive leaf, saffron and Chios mastic resin. Exact suppliers, origin documentation and final ingredient specifications remain under evaluation.
What will the shelf life be?
Shelf life has not been established. It will be determined through development and testing of the finished drink in its final packaging.
Will it need refrigeration?
Storage requirements have not been established. We will publish the validated instructions for unopened and opened products before launch.
Will it need mixing or preparation?
The planned format is a ready-to-drink beverage. Final serving and storage instructions will be provided with the finished product.
How much will it cost?
Retail prices have not been confirmed. Pricing and purchase options will be shared when the product is ready to launch.
Does ELX-13 promise longevity or cell regeneration?
No. ELX-13 has not established finished-product effects on lifespan, biological ageing or cell regeneration. Ingredient research helps inform development and does not prove that the drink will produce a health outcome.
What will the drinks taste like?
Taste development is still in progress. Final flavour descriptions will be published after the recipes have been evaluated.
Where can I find allergen and suitability information?
The final ingredient list, allergens and suitability information will be published before launch. Current concept images and development notes should not be used to make a personal suitability decision.
How can I contact ELX-13 about investment or a partnership?
Use the Partners & investors page to send a relevant enquiry. Investor materials and technical discussions are handled separately from the Founding List.
DEVELOPMENT STATUS
What is confirmed — and what comes next.
The collection is planned as three still 355 ml drinks: Olive, Saffron and Mastic. Zero sugar and natural sweetening are development targets. Final ingredients, amounts, sourcing, packaging, shelf life and storage instructions remain under evaluation.